High Plasma Levels of Fibroblast Growth Factor 23 Are Associated with Increased Risk of COVID-19 in End-Stage Renal Disease Patients on Hemodialysis: Results of a Prospective Cohort

End-stage renal disease (ESRD) patients are a population with high rates of COVID-19 and mortality. These patients present a low response to anti-SARS-CoV-2 immunization, which is associated with immune dysfunction. ESRD patients also present high plasma titers of Fibroblast Growth Factor 23 (FGF23)...

Descripción completa

Detalles Bibliográficos
Autores principales: Toro, Luis, Michea, Luis, Parra-Lucares, Alfredo, Mendez-Valdes, Gabriel, Villa, Eduardo, Bravo, Ignacio, Pumarino, Catalina, Ayala, Patricia, Sanhueza, María Eugenia, Torres, Ruben, Elgueta, Leticia, Chavez, Sebastian, Rojas, Veronica, Alvo, Miriam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9963549/
https://www.ncbi.nlm.nih.gov/pubmed/36828412
http://dx.doi.org/10.3390/toxins15020097

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9963549/
https://www.ncbi.nlm.nih.gov/pubmed/36828412
http://dx.doi.org/10.3390/toxins15020097

Ejemplares similares